Apparatus and method for wound infection prevention

Information

  • Patent Grant
  • 10085892
  • Patent Number
    10,085,892
  • Date Filed
    Friday, February 28, 2014
    10 years ago
  • Date Issued
    Tuesday, October 2, 2018
    6 years ago
Abstract
A wound healing device and method that greatly reduces the risk of infection of an incision or wound by removing fluid from the subcutaneous skin layers. The wound healing device includes a first portion that is positioned external of, and on top of, the wound. At least one strip, cord, finger, member is in fluid communication at one end with the first portion while the second free end of the at least one strip, cord, finger, member is pushed down into the wound, in between the sutures or staples of a closed incision. Both the first portion and the at least one strip comprise fluid absorbable material for absorbing the wound fluid. The device remains in place for approximately 1-3 days after which it is removed. Upon removal, natural temporary “type of fistulae” are formed in the subcutaneous skin layers to continue draining wound fluids outward for another 1-2 days.
Description
BACKGROUND OF THE INVENTION

The present invention relates generally to apparatus and methods for treating wounds, and more particularly, to an apparatus and method for healing closed incisions following surgery.


America wastes over a billion dollars annually, on post-operative surgical site infection expenses. These surgeries have an acknowledged overall infection rate of between 15%-30%. Surgical site infection slows the recovery rate for patients and adds additional health costs with prolonged hospital treatment, additional home care, physician office and emergency room visits expenses.


Typically, physicians often respond to the risk of wound infection with the “open wound” technique, subjecting patients to psychological torment of the patient knowing they have an open wound, restricting them from normal activity. The patient is left with a hole in their body open to the outside; which requires additional health maintenance including additional dressing changes by visiting nurses, additional physician consultation and additional high cost of vacuum device usually for a week or longer.


Physicians, attempts to avoid an open wound, will often install a drainage device in the patient. This is accomplished by placing a plastic tube into the patient, horizontally along the fascia layer and closing the wound around the tube. The most common drains; the “J-Drain”, and “Penrose Drain”, do not remove fluid from all three layers of skin, have a tendency to clog up and can even increase the production of additional fluid in patients; at times making the infection and recovery issues worse. The drains must then eventually be removed by surgeon, sometimes weeks after surgery. Research shows these drains have a poor rate of success with some studies showing an actual increase in patient complications.


Patients enduring the traditional old fashioned healing systems frequently require weeks to recover, extensive follow-up treatments and procedures and have increased the risk of complications and even death.


Recently, open wound “negative pressure” treatments are now also being touted as the answer for closed incision as well as open wound infection preventative treatments; this treatment simply removes excess fluid from cutaneous areas from the outer skin level. Negative pressure treatments fail to effectively address the underlining cause of surgical site infection (SSI) in closed incisions. The negative pressure VAC (vacuum) systems are also very expensive and are physician and nurse-labor intensive. The data surrounding the VAC systems appears to be mixed and studies appear to show that these systems involve patients with fewer high risk factors prior to surgery.


SSI infections may occur from the following, but not limited to: colorectal, general surgery, OBGYN, urology, vascular, neurosurgery and other procedures. The incisions or wounds closed following their respective surgeries are susceptible to high infection rates and slow patient recovery periods which also impact the physician, staff, hospital, insurer, etc. Moreover, SSI costs hospitals billions of dollars every year in the U.S. and insurance companies do not reimburse hospitals for maladies caused by infection, and corresponding complications, due to surgical site infection.


Thus, there remains a need for an apparatus and associated method that enables the physician to close the wound without significantly increasing the risk of surgical site infection to the patient, thereby being able to safely close more patients following surgery and improving their lives. The apparatus and associated method is easy to remove from the patient and is a cost effective solution.


All references cited herein are incorporated herein by reference in their entireties.


BRIEF SUMMARY OF THE INVENTION

A wound healing device for applying within an incision or wound is disclosed. The wound healing device comprises: a first portion (e.g., a dressing, bandage, etc.) that is applied over the incision or wound (e.g., open or closed), wherein the first portion comprises a fluid absorbent material (e.g., any natural or synthetic material, such but not limited to: cotton, Teflon, nylon, packing material, etc.); a second portion (e.g., strip, loop, tab, cord, appendage, tentacle, finger, etc.) that is in fluid communication and comprises a fluid absorbent material or materials material (e.g., any natural or synthetic material, such but not limited to: cotton, Teflon, nylon, packing material, etc.) with the first portion at a first end of the second portion and a second end of the second portion that is positioned within the wound in the subcutaneous skin layer, wherein the second portion comprises a fluid absorbent material (e.g., any natural or synthetic material, such but not limited to cotton, nylon, packing material, etc.).


A method for wound healing that greatly reduces the chances for infection of an incision or wound (e.g., open or closed) of a patient is disclosed. The method comprises: inserting one end of at least one fluid absorbing material (e.g., any natural or synthetic material, such but not limited to cotton, Teflon, nylon, packing material, etc.) inside the incision or wound; positioning a second end of said at least one fluid absorbing material (e.g., strip, loop, tab, cord, appendage, tentacle, finger, etc.) which in itself permits the inclusion of air into the incision, to be in fluid communication with another fluid absorbent material (e.g., a dressing, bandage, etc. and also comprising any natural or synthetic material, such but not limited to cotton, Teflon, nylon, packing material, etc.) that is positioned external of the patient and over top of the incision or wound; and maintaining said at least one fluid absorbing material and said another fluid absorbent material within and top of the incision or wound respectively, for approximately 1-3 days for conveying fluid out of the incision or wound and into the another fluid absorbent material. Because of the communication between the (e.g., strip, loop, tab, cord, appendage, tentacle, finger, etc.) and the outer dressing, the (e.g., strip, loop, tab, cord, appendage, tentacle, finger, etc.) cannot be accidentally left inside the patient.


A wound healing device for applying within an incision or wound (e.g., open or closed) is disclosed. The wound healing device comprises: at least one fluid absorbent material (e.g., any natural or synthetic material, such but not limited to: cotton, Teflon, nylon, packing material, etc.) formed into a strand (e.g., strip, loop, tab, cord, appendage, tentacle, finger, etc.) having a first end that is positioned within the wound or incision in the subcutaneous skin layer and wherein the strand further comprises a second free end that protrudes out of the wound or incision.


A method for wound healing that greatly reduces the chances for infection of an incision or wound (e.g., open or closed) of a patient is disclosed. The method comprises: forming at least one strand of a fluid absorbing material (e.g., any natural or synthetic material, such but not limited to cotton, Teflon, nylon, packing material, etc.); inserting a first end of said at least one strand (e.g., strip, loop, tab, cord, appendage, tentacle, finger, etc.) inside the incision or wound; positioning a second free end of said at least one strand to be positioned external of the patient; and maintaining said first end of said at least one strand within the incision or wound for approximately 1-3 days for conveying fluid out of the incision or wound and into said strand.





BRIEF DESCRIPTION OF SEVERAL VIEWS OF THE DRAWINGS

Many aspects of the present disclosure can be better understood with reference to the following drawings. The components in the drawings are not necessarily to scale, emphasis instead being placed upon clearly illustrating the principles of the present disclosure. Moreover, in the drawings, like reference numerals designate corresponding parts throughout the several views.



FIG. 1A is bottom view of the wound healing device of the present invention;



FIG. 1B is a side view of the wound healing device of the present invention;



FIG. 1C is top view of the wound healing device;



FIG. 2A is a functional diagram of the wound healing device in place in the closed incision or wound (e.g., in a patient's abdominal wall);



FIG. 2B is a functional diagram of the closed incision following the removal of the wound healing device, showing the formation of type of fistulae in the subcutaneous tissue;



FIG. 3A is a second more simplified embodiment of the wound healing device;



FIG. 3B is bottom view of the second embodiment;



FIG. 3C is a top view of the second embodiment;



FIGS. 4A-4M depict a surgeon or other healthcare technician applying the wound healing device of the present invention;



FIG. 5 depicts a third embodiment of the present invention which uses a continuous loop for the absorbent member that is disposed in the wound;



FIG. 6 depicts a fourth embodiment that uses a packing strip for the dressing and to which the absorbent members are coupled;



FIG. 7 depicts a fifth embodiment that uses a packing strip for the dressing and to which a continuous loop absorbent member is coupled;



FIG. 8 depicts a sixth embodiment of the present invention that uses extendable absorbent members fed from respective dispensers on or from within the dressing;



FIG. 9 depicts a seventh embodiment of the present invention that also uses extendable absorbent members that have extensions in the form of loops that pass through the present invention;



FIG. 9A depicts a variation of the seventh embodiment of the present invention that also uses extendable absorbent members that have extensions in the form of loops that are positioned within the bandage portion of the present invention;



FIG. 10 depicts an eighth embodiment of the present invention that also uses extendable absorbent members wherein the extensions are formed from excess material formed into loops on the absorbent members;



FIG. 11 depicts a ninth embodiment of the present invention wherein the absorbent member comprises foldable component that can be expanded into the wound once the absorbent member is passed into the closed incision;



FIG. 12 depicts a tenth embodiment of the present invention wherein the absorbent members are not in direct contact with the dressing but wherein fluids absorbed into the absorbent members can jump or leap into the dressing;



FIG. 13 depicts an eleventh embodiment of the present invention wherein the absorbent members are positioned within the wound without any coupling to a dressing and to which at a later stage a dressing may or may not be placed into contact with the portion of the absorbent members that extends out of the wound;



FIG. 14 is a functional diagram of the wound healing device in place in an open incision or wound (e.g., in a patient's abdominal wall);



FIG. 15 is a plan view of the dressing of another variation of the wound healing device that includes a cutaway along its edge to accommodate an obstruction, such as a stoma, closely adjacent the incision or wound; and



FIG. 15A is a plan view of a further embodiment of the wound healing device that includes an opening in the dressing that permits an obstruction to pass through the dressing to permit the dressing to make sufficient contact with the skin when the incision or wound is closely adjacent the obstruction.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Referring now to the figures, wherein like reference numerals represent like parts throughout the several views, exemplary embodiments of the present disclosure will be described in detail. Throughout this description, various components may be identified having specific values, these values are provided as exemplary embodiments and should not be limiting of various concepts of the present invention as many comparable sizes and/or values may be implemented.


The wound healing device (WHD) 20 of the present application absorbs fluid from all three layers of skin, removes fluid where infection is most common—along the incision. The WHD 20 does not clog, does not involve making additional holes in patient and exhibits the highest success rate of any infection reduction system on the highest infection risk patients—patients with multiple additional high risk factors including but not limited to: contaminated incision, diabetes, and malnutrition. As will be discussed in detail, the WHD 20 is a complete fluid absorption system.


As will also be discussed below, the WHD 20 is completely removed from the patient without re-stitching or stapling usually two days following surgery. In many patients once the WHD 20 is removed, no other dressings are necessary. In most cases where an additional light dressing is required, it is usually removed within another day or two.


One of the key features of the WHD 20, as will also be discussed below, is that it is the only device that absorbs fluid and infectious materials at the source during and after the source has formed and the WHD 20 moves the fluid and materials out of the body. Recent data using the WHD 20 cites the infection rate using at 4.2% and in cases where infection did occur, the infection was less severe and covered a smaller area. This data is virtually identical to the probe techniques studies where the patient's wound is cleaned daily with a deep insertion of cotton swabs, for five days following surgery. The probe methodology data is very similar to that related to the WHD 20; with infection rates of 3% and 4% and patients' hospital stays being reduced from 7 to 5 days, per patient. However, even though the probe technique is highly effective, it still requires daily cleaning of wound by physician for five days, and involves significant patient discomfort. It is a labor intensive solution. In contrast, the WHD 20 offers virtually identical results, using very similar concept but without the need of extensive physician labor, potentially high patient discomfort and mental anguish and still only removes the fluid and potentially infectious material after it has collected subcutaneously.


The preferred embodiment of the WHD 20 (see FIGS. 1A-1C) comprises a first portion 22 that is positioned on top of the patient's skin over the wound. This first portion 22 may referred to as a “dressing”. The dressing 22 may comprise any material, either natural or synthetic, or a combination, that can absorb fluids; for example, but not limited to, cotton, Teflon, nylon, packing material, etc. Although FIG. 1A depicts the dressing 22 as comprising a rounded rectangular shape, the dressing 22 is not limited to that shape and may assume any shape or size but as long as it comprises a fluid-absorbing characteristic. The dressing 22 may comprise a single layer or multi-layered construction, and may also be in combination with the use of non-adhering and/or medicated bandage materials and/or materials that control the direction of wicking of liquids.


In fluid communication with the first portion 22 is a second portion 24 that may comprise at least strip 24 that also comprises a fluid-absorbing characteristic. This second portion or strip 24 may comprise a single element of fluid-absorbing characteristic or it may comprise a looped construction, such as that shown by 24A in FIG. 1A. It should be understood that the physical construction of the strip 24 can vary and can be referred to using any number of terms, such as but not limited to, strip, loop, tab, cord, appendage, tentacle, finger, etc. but as long as the strip 24 comprises a fluid-absorbing characteristic. The composition of the strip 24 may comprise any natural or synthetic material such as, but not limited to, cotton, nylon, etc. By way of example only, six strips 24 are shown in fluid communication with the first portion 22. It is also within the broadest scope of the invention to include materials that control the direction of wicking of liquids. This may also be in combination with the use of non-adhering and/or medicated bandage materials. Moreover, it also within the broadest scope of the invention wherein each of the second portion or strips 24 may comprise a tong-like, or comb-like, form to guide or assist in placing or positioning them within in an open or closed wound or incision.


The fluid communication of the second portion 24 to the first portion 22 can be achieved in several ways, one of which is by stitching or via any other method of physically-connecting the first 22 and a first end 25A of the second portion 24, as shown by way of example only in FIG. 1A. However, it is within the broadest scope of the present invention 20 to include the conveyance of fluid from the second portion 24 into the first 22 by way of the fluid “wicking” across a slight gap between an end of the second portion 24 and the first portion 22. This is shown most clearly in FIG. 12 where fluid 12 absorbed into the second portion 24 “leaps” or “jumps” from the extreme end of the second portion 24 through a spacer 31, that physically separates the second portion 24 from the first portion 22, and is finally absorbed into the first portion 22. Thus, the use absorbent members 24 that are not directly in contact with the bandage 22 are within the broadest scope of the invention 20.


The length of the second portion 24 is approximately 2-3 inches, although the length could vary to 4 inches or even 8 inches, depending upon the size of the patient.



FIGS. 3A-3C shown a second, more simplified version of the WHD 20A wherein the first portion 22 comprises a swath of gauze that can be folded into a multi-layer construction and then closed 33 (e.g., stitched) to avoid the first portion 22 from unraveling. Other than that, the WHD 20A operates in the same manner as the WHD 20.



FIG. 2A depicts a functional diagram of how the WHD 20/20A works when installed in the wound of the patient. In particular, the surgeon or other healthcare attendant pushes each strip 24 through a portion of the closed incision, in between the wound staples or sutures. By way of example only, the WHD 20/20A shown in FIG. 2A shows the invention with six strips 24 positioned deep inside the closed incision 15 and positioned in the subcutaneous layer tissue 16 above the muscle 18. The first portion (dressing) 22 is positioned on the outer skin 14 directly over the closed incision 15. Fluids that form in this layer are absorbed by the strips 24 and are drawn upward, as shown by arrows 32, out of the skin layers 14/16 and into the first portion (dressing) 22. By removing fluid from these skin layers immediately, the chances for infection are greatly reduced.


Moreover, upon removal of the WHD 20/20A from the wound in approximately 1-3 days, removal of the strips 24 leaves behind respective “type of fistulae” 34 (see FIG. 2B) within the subcutaneous skin 16 and skin 14 layers. These type of fistulae provide temporary “channels” that permit fluid in the subcutaneous layer 16 to continue to escape upward for a finite time, after removal of the WHD 20/20A, further draining this layer 16 of fluid, and allowing air to enter the wound. In particular, once the WHD 20/20A is removed from the wound 15, a conventional bandage (not shown) is placed over the wound 15. These types of fistulae 34 continue to drain fluid upward towards the conventional bandage, thereby removing even more fluid from the subcutaneous layer 16. Eventually, these type of fistulae 34 naturally close, from the bottom upward, after a few additional days (e.g., 1-2 days) following the removal of the apparatus but they facilitate in draining the subcutaneous layer 16 even more. Thus, the WHD 20/20A also provides temporary draining channels for such fluid that are not formed in the subcutaneous layer 16 by other conventional draining equipment. These types of fistulae 34 serve as a natural drainage system that work in conjunction with the patient's normal healing process and the subsequent closure of the fistula.



FIGS. 4A-4M depict an exemplary WHD 20/20A application process. Although these figures show the use of only two loops 24A, it should be understood that this is simply by way of example and that just one, or more than two strips/loops could be used.


After the surgery, in the domain of sutures or staples 17 of the skin 14 of the subcutaneous, of the subcutaneous 16, and of the fascia, the wound and subject area 15, may be contaminated or clean contaminated or infected wound in which liquid may accumulate and/or colonize bacteriologically, collecting from any and or all layers.


As mentioned earlier, the absorbent dressing 22 is located on the surface of the wound 15 and subject area. Transfer of liquid and waste material from the wound and subject area to the dressing 22 is realized by capillary transfer and any other method of transfer of the absorbent strip, loop, cord or tube or appendage 24 connected or adjacent to the dressing 22 to facilitate the transfer of liquid and material from the wound area dressing 22 is provided with one or more strip, loop, cord or tube or appendage 24 which is, or is located in the area of the wound 15, infected or potentially infected area and therefore facilitates the flow of liquid and bodily waste materials from the subcutaneous 16 to the dressing absorbent material 22 outside the patient body.


The facilitation of the liquid and bodily materials especially from the incision wound 15, infected or potentially infected area or injury area, from potentially any and all subcutaneous areas and levels 16, into absorbent or liquid extractable strips, loops, cords, tubes or absorbent appendage 24 towards and into the adjacent or attached absorbent materials external to the body.


In particular, FIG. 4A shows a wound 15 in the skin 14 closed with staples 17, where gaps 19 between the staples 17 allow the passage of the strips 24, as discussed below; the extreme end (i.e., second end 25B) of one strip 24 can be seen at the top of FIG. 4A, being moved over a surgical covering 11.



FIG. 4B depicts the WHD 20/20A being positioned over the wound 15 (not visible in FIG. 4B); it should be noted that the WHD 20/20A includes an adhesive border (not shown) which is covered by a release border 36 along the edge of the first portion 22.



FIG. 4C shows the surgeon or other healthcare attendant manipulating the WHD 20/20A such that one of the strips 24 is positioned over a gap 19 between staples 17. FIG. 4D shows the surgeon or healthcare attendant (hereinafter “surgeon”) further manipulating the WHD 20/20A in order to properly position one of the strips 24 over a gap 19 in the wound 15 between staples 17. FIG. 4E shows the surgeon seizing one of the strips 24 with a clamp 2 in preparation to push the strip 24 into the gap 19; in FIG. 4F, the surgeon is pushing the free end of the strip 24 into a gap 19 in the wound 15.



FIGS. 4G-4H shows the surgeon inserting another strip 24 into another gap 19 in the wound 15. Typically, the surgeon pushes the free end of the strip 24 down into the gap 19 and obtains a tactile indication to stop when the surgeon feels contact with the fascia layer is made.



FIG. 4I shows both strips 24 pushed down into respective gaps 19 in the wound 15 between staples 17.


At this point, the surgeon needs only to secure the first portion (dressing) 22 down onto the skin 14 of the patient using the adhesive border. FIGS. 4J-4K show the surgeon applying the first portion 22 onto the skin 14 and then removes the release liner 36 from the first portion 22. FIG. 4M depicts the WHD 20/20A releasably secured in place in and over the wound 15. By way of example only, a transparent adhesive 37 overlays the top surface of the dressing 22 (and to which the release liner 36 was originally attached) that releasably secures the dressing 22 to the skin 14.



FIG. 5 depicts a third embodiment of the WHD 20B wherein the at least one strip 24 is replaced by a continuous absorbent member 24B that is formed into a large loop. The loop 24B comprises ends that correspond to ends of the first portion 22.



FIG. 6 depicts a fourth embodiment of the WHD 20C wherein the first portion 22 is formed of a thin packing material 22A.



FIG. 7 depicts a fifth embodiment of the WHD 20D which is a combination of the third and fourth embodiments. In particular, the first portion 22A is formed of a thin packing material 22A and the at least one strip 24 comprises the large loop 24B. As with the third embodiment 20B, the WHD 20D comprises the loop 24 having ends that correspond to the ends of the first portion 22.


Another key improvement to the WHD 20/20A is the ability to extend the length of the at least one strip 24A. This can be advantageous for a number of reasons. Allowing the surgeon to adjust the length of the at least one strip 24 permits the surgeon to customize the absorbing capability of the present invention 20 based on the patient's physiology. If, by way of example, the patient has a large girth, it may be necessary to extend the length of the at least one strip 24, deeper into the subcutaneous layer 16.


To that end, FIG. 8 depicts a sixth embodiment 20E wherein respective cartridges 38 of strip material permit the strips 24 to be extended to new lengths 24′, shown in phantom. Alternatively, FIG. 9 shows the use of “slack loops” 40 in a seventh embodiment 20F that project from the upper side of the first portion 22. Thus, when it becomes necessary to extend the lengths of the strips 24, the surgeon can push downward on each strip 24 to extend the length of each strip to that shown by 24″ by a corresponding decrease 40′ in the slack loops 40. It should be understood that the term “slack loops” in their broadest sense may include rolled, or folded or tucked fluid absorbent material strips that are located inside or outside the first portion 22; FIG. 9A shows an exemplary embodiment 20F1 where the “slack loops” are provided within the first portion 22 itself. The arrow indicates movement as the strip 24 is lengthened and the slack loops 40 are shortened.



FIG. 10 depicts an eighth embodiment 20G that uses “slip knots” 42 in each strip 24 that allow each strip 24 to be lengthened by applying a downward force on each strip 24; excess material formed in the slip know 42 permits the respective strip 24 to be lengthened 42′.



FIG. 11 depicts a ninth embodiment 20H wherein the second portion 24C comprises a foldable portion 44 that can be expanded outward within the subcutaneous layer 16 once the second portion 24C is passed through a gap 19 in the wound 15. In particular, once the second portion 24 is pushed downward in the gap 19, the surgeon can then expand the foldable portion 44 along the length of the wound 15 within the subcutaneous layer 16.


A further variation 20J of the present invention 20 is the use of free absorbent members 24 being placed into the wound in between the staples or sutures 17, wherein the upper ends 24C of the absorbent members are free, as shown most clearly in FIG. 13. In particular, the surgeon or other healthcare technician can insert each of these free absorbent members 24 in between the sutures or staples 17 in the subcutaneous layer tissue 16 above the muscle 18, as described previously. As also mentioned previously, these free absorbent members 24 may remain in the wound for approximately 1-3 days at which time they are then removed by the surgeon or other healthcare technician. As also mentioned earlier, fluids that form in the wound are absorbed by the strips 24 and are drawn upward, out of the skin layers 14/16. By removing fluid from these skin layers immediately, the chances for infection are greatly reduced. Furthermore, the fistulae 34 are also formed as described earlier with regard to FIG. 2. A separate dressing 22 may also be applied to the upper ends 24C during the time the free absorbent members 24 inserted into the wound, although this is not required.


It should be understood that it is within the broadest scope of the present invention to include the use of all of the embodiments of the WHD in open wounds also. By way of example only, as shown FIG. 14, the WHD 20 is placed inside an open wound, i.e., where no sutures or staples are used to close the wound. Thus, the surgeon places the strips 24 down into the open wound with the dressing 22 being placed at the skin level. Also by way of example only, the variation 20J discussed previously can be placed also into the open wound and then a separate dressing 22 may be placed in contact with the upper ends 24C of the free absorbent members 24.



FIGS. 15 and 15A provide further embodiments of the WHD to accommodate surrounding items or obstructions at the skin surface that would prevent the dressing 22 from making good contact with the skin surface. In particular, FIG. 15 depicts a top view of this additional WHD embodiment 20K whose first portion 22 comprises a dressing edge removed, forming a cutaway 46. For example, a where a patient has a stoma having a tube or other lumen that is coupled thereto and the wound or incision is closely adjacent that stoma, the WHD embodiment 20K can be positioned as described previously and the dressing 20 can be positioned such that the cutaway 46 is positioned closely adjacent the stoma/tube, thereby allowing the edges of the dressing 22 of the WHD 20K to make good contact with the skin surface and not be interfered with by the stoma/tube. It should be further understood that the shape of the cutaway 46 is by way of example only and it is not limited to a semi-circular contour but may comprise any shape and size. In addition, the relative position of the cutaway 46 can be located along any edge of the dressing 22.



FIG. 15A shows another embodiment 20L of the WHD wherein an interior portion forming an opening 48 of the dressing 22 is removed. Thus, where the incision or wound is located at a position closely adjacent some obstruction (e.g., a stoma, a tube, a medical device or sensor, etc.) that would prevent the dressing 22 from making sufficient contact with the skin surface, the obstruction (not shown) can be passed through the opening 48 to permit the dressing 22 to be positioned flush against the skin surface. Again, the opening 48 is shown by way of example only; other shapes and other locations on the dressing 22 may comprise the opening 48.


It should be noted that although not required, an anti-microbial composition may be applied to either the first portion 22 and/or the second portion 24.


Thus, the present invention relates to an apparatus/method of wound infection prevention and healing acceleration and life. The WHD 20 provides the effective post-surgical clean contaminated, contaminated, clean and infected incision when the rate of infection potential is considered significant. The apparatus/method may also be used in a variety of medical surgeries interventions and procedures. The present invention 20 can also be used in veterinary medicine.


The apparatus & method for wound infection device (WHD) 20 is useful for preventing SSI infection for the following surgeries including but is not limited to: general surgery procedures, colorectal, OBGYN procedures, urology, vascular surgeries, and neurosurgery procedures. The incisions or wounds closed following their respective surgeries are susceptible to high infection rates and slow patient recovery periods which also impact the physician, staff, hospital, insurer, etc. Moreover, SSI costs hospitals billions of dollars every year in the U.S. and insurance companies do not reimburse hospitals for maladies caused by infection, and corresponding complications, due to surgical site infection.


It should be further understood that the term WHD includes any all of kinds of kits that comprise the WHD and any associated components (e.g., a plurality of WHDs; tools that may be used by the surgeon to insert the second portion 24 into wound site (e.g., pliers, tweezers, dissectors, etc.) that are provided with the WHD 20 itself.


Thus, the apparatus and method for wound infection device (WHD) 20 accelerates the healing process by reducing the healing time by an average of 2 days per patient, which among other things, reduces hospital stay periods.


While the invention has been described in detail and with reference to specific examples thereof, it will be apparent to one skilled in the art that various changes and modifications can be made therein without departing from the spirit and scope thereof.

Claims
  • 1. A wound healing device comprising: a first portion that is configured to be applied over and external to a wound, said first portion comprising a first fluid absorbent material;a second portion that is in fluid communication with said first portion at a first end of said second portion and a second end of said second portion that is configured to be positioned within the wound in a subcutaneous skin layer, said second portion comprising a second fluid absorbent material; andwherein said first portion comprises a central portion to which said first end is coupled and wherein said first portion is adapted to form a cover over the wound when said second end is positioned within the wound, said first and second portions being a removable device, wherein the first fluid absorbent material with a first fluid-absorbing characteristic and the second fluid absorbent material with a second fluid-absorbing characteristic different from the first fluid-absorbing characteristic are configured to wick liquids from the second portion to the first portion to facilitate removal of fluid and potentially infectious materials from the subcutaneous skin layer.
  • 2. The wound healing device of claim 1 wherein said second portion comprises at least one strip and wherein said first end is physically coupled to said first portion.
  • 3. The wound healing device of claim 1 wherein the first fluid absorbent material and the second fluid absorbent material are further constructed to wick infectious materials from the second portion to the first portion.
  • 4. The wound healing device of claim 1 wherein the second portion is one of a plurality of second portions that are in fluid communication with said first portion.
  • 5. The wound healing device of claim 1 wherein the second portion is configured to be placed in the wound between sutures or staples.
  • 6. The wound healing device of claim 1 wherein the second portion is configured to be placed in the wound where no sutures or staples are used to close the wound.
  • 7. The wound healing device of claim 1 wherein the first portion and the second portion are physically connected.
  • 8. The wound healing device of claim 1 wherein the second portion within the wound is configured to allow air to enter the wound.
  • 9. The wound healing device of claim 1 wherein said second portion comprises at least one strip and wherein said first end is stitched to said first portion.
  • 10. The wound healing device of claim 9 wherein said at least one strip comprises a loop.
  • 11. The wound healing device of claim 9 wherein said at least one strip comprises a packing strip.
  • 12. The wound healing device of claim 1 wherein said first portion comprises gauze.
  • 13. The wound healing device of claim 1 wherein said second portion is extendable.
  • 14. The wound healing device of claim 13 wherein said first portion comprises a material cartridge for said second portion, said material cartridge is configured to be activatable to dispense material to permit a length of said second portion to be extended.
  • 15. The wound healing device of claim 13 wherein said second portion comprises at least one strip and wherein said first portion comprises a slack loop configured to be adjustable to permit a length of said at least one strip to be extended.
  • 16. The wound healing device of claim 13 wherein said second portion comprises at least one strip that comprises a slip knot configured to be adjustable to permit a length of said at least one strip to be extended.
  • 17. The wound healing device of claim 13 wherein said second portion comprises a foldable portion configured to be expandable to expand along a length of the wound within the subcutaneous skin layer.
  • 18. The wound healing device of claim 1 wherein said first portion comprises a packing strip.
  • 19. A wound healing device comprising: at least one fluid absorbent material formed into a strand having a first end that is configured to be positioned within a wound in direct contact with a subcutaneous skin layer, said at least one fluid absorbent material strand further comprising a second end; anda dressing portion that is coupled with said second end of said at least one fluid absorbent material strand; andwherein said dressing portion comprises a central portion with a fold line configured to position and facilitate a fold to which said second end is coupled and wherein said dressing portion is adapted to unfold to form a cover over and external to the wound when said first end is positioned within the wound, said at least one fluid absorbent material strand and said dressing portion being a removable device, wherein said at least one fluid absorbent material strand and said dressing portion are constructed to control wicking of liquids from the subcutaneous skin layer to the dressing portion to facilitate transfer of the liquids and material from the wound.
  • 20. The wound healing device of claim 19 wherein the wound is a closed incision and wherein said first end that is configured to be positioned within the wound is positioned in between sutures or staples of the closed incision.
  • 21. The wound healing device of claim 19 wherein the at least one fluid absorbent material strand and the dressing portion are further constructed to control wicking of infectious materials from the subcutaneous skin layer to the dressing portion.
  • 22. The wound healing device of claim 19 wherein the at least one fluid absorbent material strand is one of a plurality of fluid absorbent strands that are in fluid communication with the dressing portion.
  • 23. The wound healing device of claim 19 wherein the at least one fluid absorbent material strand is physically connected to the dressing portion.
  • 24. The wound healing device of claim 19 wherein the at least one fluid absorbent material strand and the dressing portion that are physically separate are configured to be in contact over the wound.
  • 25. The wound healing device of claim 19 wherein the first end within the wound is configured to allow air to enter the wound.
  • 26. An apparatus comprising: a first fluid absorbent material that is configured to be applied over and external to a wound; anda second fluid absorbent material in fluid communication with the first fluid absorbent material, the second fluid absorbent material configured to be positioned within the wound in direct contact with a subcutaneous skin layer to facilitate wicking of liquids and waste materials towards the first fluid absorbent material, wherein the first fluid absorbent material and the second fluid absorbent material are composed of different materials.
  • 27. The apparatus of claim 26 wherein the first fluid absorbent material and the second fluid absorbent material are further configured to wick infectious materials towards the first fluid absorbent material.
  • 28. The apparatus of claim 26 wherein the second fluid absorbent material is one of a plurality of second fluid absorbent materials that are in fluid communication with the first fluid absorbent material.
  • 29. The apparatus of claim 26 wherein the second fluid absorbent material is configured to be placed in the wound between sutures or staples.
  • 30. The apparatus of claim 26 wherein the first fluid absorbent material and the second fluid absorbent material are physically connected.
  • 31. The apparatus of claim 26 wherein the second fluid absorbent material within the wound reduces risk of infection and encourages formation of a fistula within the subcutaneous skin layer, thereby promoting continuing drainage of the liquids from the subcutaneous skin layer subsequent to removal of the second fluid absorbent material from the subcutaneous skin layer approximately 1-3 days after positioned within the wound.
  • 32. The apparatus of claim 26 wherein the second fluid absorbent material encourages formation of a fistula within the subcutaneous skin layer that promotes continuing drainage of the liquids from the subcutaneous skin layer subsequent to removal of the second fluid absorbent material from the subcutaneous skin layer.
  • 33. The apparatus of claim 26 wherein second fluid absorbent material configured within the wound is configured to permit air into the wound.
  • 34. The apparatus of claim 26 wherein said second fluid absorbent material comprises at least one strip physically coupled to said first fluid absorbent material.
  • 35. The apparatus of claim 26 wherein said second fluid absorbent material comprises at least one strip stitched to said first fluid absorbent material.
  • 36. The apparatus of claim 35 wherein said at least one strip comprises a loop.
  • 37. The apparatus of claim 35 wherein said at least one strip comprises a packing strip.
  • 38. The apparatus of claim 26 wherein said first fluid absorbent material comprises gauze.
  • 39. The apparatus of claim 26 wherein said second fluid absorbent material is extendable.
  • 40. The apparatus of claim 39 wherein said first fluid absorbent material comprises a material cartridge for said second fluid absorbent material, said material cartridge is configured to be activatable to dispense material to permit a length of said second fluid absorbent material to be extended.
  • 41. The apparatus of claim 39 wherein said second fluid absorbent material comprises at least one strip and wherein said first fluid absorbent material comprises a slack loop configured to be adjustable to permit a length of said at least one strip to be extended.
  • 42. The apparatus of claim 39 wherein said second fluid absorbent material comprises at least one strip that comprises a slip knot configured to be adjustable to permit a length of said at least one strip to be extended.
  • 43. The apparatus of claim 39 wherein said second fluid absorbent material comprises a foldable portion configured to be expandable to expand along a length of the wound within the subcutaneous skin layer.
  • 44. The apparatus of claim 26 wherein said first fluid absorbent material comprises a packing strip.
  • 45. An apparatus comprising: a first portion that is configured to be applied over and external to a wound in a body, said first portion comprising a first fluid absorbent material; anda second portion is in fluid communication with said first portion at a first end of said second portion, and a different, second end of said second portion is configured to be positioned within the wound in a subcutaneous skin layer, the different, second end of said second portion comprising a second fluid absorbent material, wherein said first portion has a fold line configured to position and facilitate a fold in said first portion to position the different, second end within the wound and said first portion is adapted to unfold to form a cover over the wound when the different, second end is positioned within the wound, and the second portion is configured to facilitate wicking of liquids and materials in the subcutaneous skin layer out of the body from the different, second end of the second portion to the first portion, wherein the first fluid absorbent material and the second fluid absorbent material have different fluid-absorbing characteristics.
  • 46. The apparatus of claim 45 wherein the first portion and the second portion are further configured to wick infectious materials from the different, second end of the second portion to the first portion.
  • 47. The apparatus of claim 45 wherein the second portion is one of a plurality of second portions that are in fluid communication with the first portion.
  • 48. The apparatus of claim 45 wherein the second portion is configured to be placed in the wound between sutures or staples.
  • 49. The apparatus of claim 45 wherein the first portion and the second portion are in physical contact.
  • 50. The apparatus of claim 49 wherein the first portion and the second portion are physically connected.
  • 51. The apparatus of claim 45 wherein the second portion is configured to expand through absorption of the liquids and to be removed from the wound in approximately 1-3 days, wherein removal of the second portion leaves behind a fistula within the subcutaneous skin layer that promotes continuing drainage of the liquids from the subcutaneous skin layer.
  • 52. The apparatus of claim 45 wherein the second portion positioned within the wound in the subcutaneous skin layer is configured to permit air into the wound.
CROSS-REFERENCE TO RELATED APPLICATIONS

This non-provisional application claims the benefit under 35 U.S.C. § 119(e) of both Application Ser. No. 61/774,272 filed on Mar. 7, 2013 entitled METHOD OF WOUND INFECTION PREVENTION AND CLEAN KIT and Application Ser. No. 61/914,720 filed on Dec. 11, 2013 entitled APPARATUS AND METHOD FOR WOUND INFECTION PREVENTION, and all of whose entire disclosures are incorporated by reference herein.

US Referenced Citations (73)
Number Name Date Kind
3682180 McFarlane Aug 1972 A
3753439 Brugarolas Aug 1973 A
4250882 Adair Feb 1981 A
4553966 Korteweg Nov 1985 A
4815457 Mazars Mar 1989 A
4917928 Heinecke Apr 1990 A
5053021 Feibus Oct 1991 A
5153040 Faasse, Jr. Oct 1992 A
5180375 Feibus Jan 1993 A
5266371 Sugii Nov 1993 A
5358492 Feibus Oct 1994 A
5531999 Cartmell Jul 1996 A
5840052 Johns Nov 1998 A
5898964 Stanley May 1999 A
5973221 Collyer et al. Oct 1999 A
6420622 Johnston et al. Jul 2002 B1
6432096 McFall Aug 2002 B1
6605068 Righetti Aug 2003 B2
6884427 Barrows Apr 2005 B1
6936037 Bubb et al. Aug 2005 B2
7182758 McCraw Feb 2007 B2
7619130 Nielsen et al. Nov 2009 B2
7709694 Batich et al. May 2010 B2
8172818 Locke et al. May 2012 B2
9456930 Zamierowski Oct 2016 B2
20010000796 Osborn, III May 2001 A1
20010027347 Rousseau Oct 2001 A1
20030004579 Rousseau Jan 2003 A1
20030093075 Levinson May 2003 A1
20030191442 Bewick-Sonntag Oct 2003 A1
20040087980 Ford May 2004 A1
20040249328 Linnane et al. Dec 2004 A1
20050033251 Toreki et al. Feb 2005 A1
20050107731 Sessions May 2005 A1
20050107756 McCraw May 2005 A1
20050148920 Addison Jul 2005 A1
20050273066 Wittman Dec 2005 A1
20060041247 Petrosenko Feb 2006 A1
20060162072 Tenenbaum Jul 2006 A1
20060163152 Ward Jul 2006 A1
20060241689 Leiboff et al. Oct 2006 A1
20080132819 Radl Jun 2008 A1
20080167593 Fleischmann Jul 2008 A1
20080206293 Toreki et al. Aug 2008 A1
20080287892 Khan Nov 2008 A1
20090105731 Priewe Apr 2009 A1
20090280182 Beck et al. Nov 2009 A1
20090313762 Boutwell Dec 2009 A1
20100036334 Heagle Feb 2010 A1
20100106122 Clemens Apr 2010 A1
20100174250 Hu et al. Jul 2010 A1
20100210745 McDaniel et al. Aug 2010 A1
20100268128 Randolph Oct 2010 A1
20100318047 Ducker Dec 2010 A1
20110015619 Svedman Jan 2011 A1
20110144667 Horton Jun 2011 A1
20110208145 Zhang Aug 2011 A1
20110240064 Wales et al. Oct 2011 A1
20110270201 Bubb Nov 2011 A1
20120077886 Scholz et al. Mar 2012 A1
20120093759 Vachon Apr 2012 A1
20120186016 Martin Jul 2012 A1
20120253302 Corley Oct 2012 A1
20130035649 Locke et al. Feb 2013 A1
20130151223 Zamierowski Jun 2013 A1
20130190408 Scholz et al. Jul 2013 A1
20130197459 Brezoczky Aug 2013 A1
20130217284 Wang Aug 2013 A1
20130274629 Duesterhoft Oct 2013 A1
20140031735 Zurovcik Jan 2014 A1
20150157774 Zamierowski Jun 2015 A1
20160270963 Zamierowski Sep 2016 A1
20160346444 Zamierowski Dec 2016 A1
Foreign Referenced Citations (1)
Number Date Country
0604101 Jun 1994 EP
Non-Patent Literature Citations (13)
Entry
Online dictionary definition of “removable.” https://www.vocabulary.com/dictionary/removable. Accessed Tuesday, Mar. 22, 2016.
Online dictionary definition of “removable.” http://www.thefreedictionary.com/removable. Accessed Tuesday, Mar. 22, 2016.
McGreal, Gerald T., et al. “Antiseptic wick: does it reduce the incidence of wound infection following appendectomy?.” World journal of surgery 26.5 (2002): 631-634.
Lee, Seung Kwon, Helmut Schreiber, and Karen Howe. “Using a full-depth wound drainage system to decrease wound infection rates in the morbidly obese.” Obesity surgery 1.4 (1991): 435-438.
“coupled”. Dictionary.com Unabridged. Random House, Inc. Sep. 16, 2016. <Dictionary.com http://www.dictionary.com/browse/coupled>.
International Search Report for corresponding PCT Application No. PCT/US2014/019519 dated Jun. 3, 2014.
Braen, et al., Manual of Emergency Medicine, 2011, p. 464.
Fulmes, et al., “Packing the Closed Incision After Open Colon Resection Can Decrease the Risk of Wound Infection. A Pilot Study,” Lehigh Valley Health Network, Department of Surgery, 2012, 3 pages.
Harper, W.W., “The Treatment of Injuries to the Soft Parts of the Hand,” International Journal of Surgery, vol. 21, Oct. 1908, pp. 303-304.
“Today's Wound Care Treatments,” Medline, May 2013.
Technical report: A silicone rubber suction drain for drainage of subdural hematomas, Frederick E. Jackson and Richard A. Pratt, Surgery, Oct. 1971: vol. 70, No. 4, 578-579.
Surgical site infections 1: New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective, Benedetta Allegranzi et al. and the WHO Guidelines Development Group, Lancet Infect Dis 2016: Published online Nov. 2, 2016 http://dx.doi.org/10.1016/S1473-3099(16)30398-X.
Surgical site infections 2: New WHO recommendations on intraoperative and postoperative measures for surgical site nfection prevention: an evidence-based global perspective, Benedetta Allegranzi et al. and the WHO Guidelines Development Group, Lancet Infect Dis 2016: Published online Nov. 2, 2016 http://dx.doi.org/10.1016/S1473-3099(16)30402-9.
Related Publications (1)
Number Date Country
20140257218 A1 Sep 2014 US
Provisional Applications (2)
Number Date Country
61914720 Dec 2013 US
61774272 Mar 2013 US